{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:14:58Z","timestamp":1786119298120,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1097\/ijg.0b013e31818624e5","type":"journal-article","created":{"date-parts":[[2009,6,10]],"date-time":"2009-06-10T03:39:32Z","timestamp":1244605172000},"page":"395-398","source":"Crossref","is-referenced-by-count":36,"title":["Exposure to Topical Apraclonidine in Children With Glaucoma"],"prefix":"10.1097","volume":"18","author":[{"given":"Tarra M.","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon F.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210208","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/0024-3205(79)90521-6","article-title":"(3H) para-aminoclonidine: a novel ligand which binds with high affinity to alpha-adrenergic receptors","volume":"25","author":"Roust","year":"1979","journal-title":"Life Sci"},{"key":"R2-9-20210208","first-page":"49","article-title":"Use of apraclonidine to reduce acute intraocular pressure rise following Q-switched Nd:YAG laser iridotomy","volume":"20","author":"Kitazawa","year":"1989","journal-title":"Ophthalmic Surg"},{"key":"R3-9-20210208","doi-asserted-by":"crossref","first-page":"657","DOI":"10.3928\/1542-8877-19960801-03","article-title":"Apraclonidine 0.5% versus 1% for controlling intraocular pressure elevation after argon laser trabeculoplasty","volume":"27","author":"Threlkeld","year":"1996","journal-title":"Ophthalmic Surg Lasers"},{"key":"R4-9-20210208","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/S0161-6420(95)30869-X","article-title":"Apraclonidine and anterior segment laser surgery. Comparison of 0.5% versus 1.0% apraclonidine for prevention of postoperative intraocular pressure rise","volume":"102","author":"Rosenberg","year":"1995","journal-title":"Ophthalmology"},{"key":"R5-9-20210208","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/bjo.79.12.1098","article-title":"Long term effect of apraclonidine","volume":"79","author":"Araujo","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"R6-9-20210208","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/sj.eye.6700520","article-title":"Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan) in children","volume":"18","author":"Bowman","year":"2004","journal-title":"Eye"},{"key":"R7-9-20210208","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1016\/j.ophtha.2005.06.035","article-title":"Side-effect profile of brimonidine tartrate in children","volume":"112","author":"Al-Shahwan","year":"2005","journal-title":"Ophthalmology"},{"key":"R8-9-20210208","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0002-9394(99)00083-5","article-title":"Apparent central nervous system depression in infants after the use of topical brimonidine","volume":"128","author":"Carlsen","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"R9-9-20210208","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1067\/mpa.2001.117571","article-title":"Safety and efficacy of brimonidine in children with glaucoma","volume":"5","author":"Enyedi","year":"2001","journal-title":"J Aapos"},{"key":"R10-9-20210208","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ajo.2006.04.052","article-title":"Efficacy of apraclonidine 0.5% in the diagnosis of Horner syndrome in pediatric patients under low or high illumination","volume":"142","author":"Chen","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R11-9-20210208","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archopht.122.2.276","article-title":"The use of apraclonidine in the diagnosis of horner syndrome in pediatric patients","volume":"122","author":"Bacal","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"R12-9-20210208","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jaapos.2007.02.015","article-title":"Adverse effects of apraclonidine used in the diagnosis of Horner syndrome in infants","volume":"11","author":"Watts","year":"2007","journal-title":"J AAPOS"},{"key":"R13-9-20210208","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0165-3806(87)90107-6","article-title":"Interendothelial junctional changes underlie the developmental \u201ctightening\u201d of the blood-brain barrier","volume":"429","author":"Stewart","year":"1987","journal-title":"Brain Res"}],"container-title":["Journal of Glaucoma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/IJG.0b013e31818624e5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:55:24Z","timestamp":1786038924000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00061198-200906000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/ijg.0b013e31818624e5","relation":{},"ISSN":["1057-0829"],"issn-type":[{"value":"1057-0829","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}